Table 1.
End of the treatment | ||||||
---|---|---|---|---|---|---|
ASIA scale | ||||||
Baseline characteristics | A; no. (%) | B; no. (%) | C; no. (%) | D; no. (%) | E; no. (%) | p value |
T1 (n = 226) | 0.02 | |||||
A (n = 153) | 73 (47.7) | 23 (15) | 57 (37.3) | – | – | |
B (n = 32) | – | 18 (56.3) | 13 (40.6) | 1 (3.1) | – | |
C (n = 36) | – | – | 31 (86.1) | 5 (13.9) | – | |
D (n = 5) | – | – | – | 2 (40.0) | 3 (60.0) | |
T2 (n = 58) | 0.01 | |||||
A (n = 32) | 20 (62.5) | 12 (37.5) | – | – | – | |
B (n = 9) | – | 7 (77.8) | 2 (22.2) | – | – | |
C (n = 17) | – | – | 17 (100) | – | – | |
T3 (n = 19) | 0.02 | |||||
A (n = 8) | 5 (62.5) | 3 (37.5) | – | – | – | |
B (n = 4) | – | 4 (100) | – | – | – | |
C (n = 7) | – | – | 6 (85.7) | 1 (14.3) | – |
ASIA, American Spinal Injury Association.